RTOG-0828

Closed to Accrual

Return to Protocol Table

Pilot Project to Reduce Missing RTOG Quality of Life Data Via Electronic Web-Based Form Collection: A Companion Study for RTOG 0415 (A Phase III Randomized Study of Hypofractionated 3D-CRT/IMRT Versus Conventionally Fractionated 3D-CRT/IMRT in Patients wi

Principal Investigator

Benjamin Movsas, MD

Status

Closed to Accrual

Date Closed to Accrual

December 10 2009

Disease Site

Genitourinary [GU]

Prostate

Phase

III

Developmental Therapeutics

Primary Objective

EPIC completion rate at 6 months. Completion rate is defined as completion of any part of the QOL forms.

Patient Population

Only English-literate patients enrolled on RTOG 0415 who consented to participate in the quality of life component of that study (at one of the specified institutions) and have an e-mail address are eligible for enrollment in this companion study.

Target Accrual

Protocol Document

RTOG-0828 protocol version date June-22-2019.pdf

Informed Consent

RTOG-0828 consent version date June-22-2019.doc

Patient Study Webpage

There is no available patient study webpage available for this trial at this time.

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.